Loading clinical trials...
Loading clinical trials...
A Study to Assess Effectiveness, Safety, and Health-related Outcomes of NUEDEXTA® (Dextromethorphan Hydrobromide and Quinidine Sulfate) for the Treatment of Pseudobulbar Affect (PBA) in Nursing Home Patients
Conditions
Interventions
NUEDEXTA®
Locations
2
United States
Miami, Florida, United States
Centerville, Ohio, United States
Start Date
September 1, 2015
Primary Completion Date
May 1, 2016
Completion Date
May 1, 2016
Last Updated
July 3, 2017
Lead Sponsor
Avanir Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions